Cellular and Molecular Life Sciences

, Volume 64, Issue 13, pp 1701–1714 | Cite as

RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies

  • J.-M. GalloEmail author
  • W. Noble
  • T. Rodriguez Martin
Biomedicine & Diseases: Review


Tauopathies are a group of neurodegenerative diseases characterised by intracellular deposits of the microtubule-associated protein tau. The most typical example of a tauopathy is Alzheimer’s disease. The importance of tau in neuronal dysfunction and degeneration has been demonstrated by the discovery of dominant mutations in the MAPT gene, encoding tau, in some rare dementias. Recent developments have shed light on the significance of tau phosphorylation and aggregation in pathogenesis. Furthermore, emerging evidence reveals the central role played by tau pre-mRNA processing in tauopathies. The present review focuses on the current understanding of tau-dependent pathogenic mechanisms and how realistic therapies for tauopathies can be developed.


Tauopathies neurodegeneration Alzheimer’s disease tau alternative splicing phosphorylation glycogen synthase kinase aggregation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Birkhäuser Verlag, Basel 2007

Authors and Affiliations

  1. 1.MRC Centre for Neurodegeneration ResearchKing’s College London, Institute of PsychiatryLondonUK

Personalised recommendations